Increased urinary leukotriene E4 excretion in obstructive sleep apnea: Effects of obesity and hypoxia

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 2, 2009, Pages

  Stanke Labesque, Françoise ^a,b,c   Bäck, Magnus ^d   Lefebvre, Blandine ^a,b   Tamisier, Renaud ^a,b,c   Baguet, Jean Philippe ^c   Arnol, Nathalie ^a,b,c   Lévy, Patrick ^a,b,c   Pépin, Jean Louis ^a,b,c  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c HÔPITAL MICHALLON   (France)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Leukotriene E4; nocturnal oxygen desaturation; obesity; obstructive sleep apnea syndrome

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; LEUKOTRIENE E4; MESSENGER RNA;

ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; HYPOXIA; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; OBESITY; OXYGEN SATURATION; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION;

EID: 67651229010     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.05.033     Document Type: Article

References (31)

1. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 (2005) 2034-2041
2. McNicholas W.T., and Bonsigore M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29 (2007) 156-178
3. Pillar G., and Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg?. Diabetes Care 31 suppl 2 (2008) S303-S309
4. Mehra R., and Redline S. Sleep apnea: a proinflammatory disorder that coaggregates with obesity. J Allergy Clin Immunol 121 (2008) 1096-1102
5. Taheri S., Austin D., Lin L., Nieto F.J., Young T., and Mignot E. Correlates of serum C-reactive protein (CRP): no association with sleep duration or sleep disordered breathing. Sleep 30 (2007) 991-996
6. Schwartz A.R., Patil S.P., Laffan A.M., Polotsky V., Schneider H., and Smith P.L. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5 (2008) 185-192
7. Mehrabian M., and Allayee H. 5-lipoxygenase and atherosclerosis. Curr Opin Lipidol 14 (2003) 447-457
8. Kim N., and Luster A.D. Regulation of immune cells by eicosanoid receptors. Sci World J 7 (2007) 1307-1328
9. Back M., and Hansson G.K. Leukotriene receptors in atherosclerosis. Ann Med 38 (2006) 493-502
10. 4 in coronary artery disease and after coronary artery bypass surgery. Coron Artery Dis 4 (1993) 899-904
11. Carry M., Korley V., Willerson J.T., Weigelt L., Ford-Hutchinson A.W., and Tagari P. Increased urinary leukotriene excretion in patients with cardiac ischemia: in vivo evidence for 5-lipoxygenase activation. Circulation 85 (1992) 230-236
12. 4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometry. Prostaglandins Other Lipid Mediat 78 (2005) 291-299
13. Spanbroek R., and Habenicht A.J. The potential role of antileukotriene drugs in atherosclerosis. Drug News Perspect 16 (2003) 485-489
14. Bäck M., Sultan A., Ovchinnikova O., and Hansson G.K. 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res 100 (2007) 946-949
15. Goldbart A.D., Krishna J., Li R.C., Serpero L.D., and Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 130 (2006) 143-148
16. Kaditis A.G., Alexopoulos E., Chaidas K., Ntamagka G., Karathanasi A., Tsilioni I., et al. Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest 135 (2009) 1496-1501
17. Kaditis A.G., Ioannou M.G., Chaidas K., Alexopoulos E.I., Apostolidou M., Apostolidis T., et al. Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea. Chest 134 (2008) 324-331
18. Dayyat E., Serpero L.D., Kheirandish-Gozal L., Goldman J.L., Snow A., Bhattacharjee R., et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 135 (2009) 1142-1149
19. Ridker P.M., Brown N.J., Vaughan D.E., Harrison D.G., and Mehta J.L. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 (2004) IV6-IV19
20. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
21. 4: early mediator of atherosclerosis in obstructive sleep apnoea?. Eur Respir J 32 (2008) 113-120
22. Sleep-related breathing disorders in adults. recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22 (1999) 667-689
23. Hosselet J., Ayappa I., Norman R.G., Krieger A.C., and Rapoport D.M. Classification of sleep-disordered breathing. Am J Respir Crit Care Med 163 (2001) 398-405
24. 4 generation by human monocytes and neutrophils stimulated by uropathogenic strains of Escherichia coli. Biochim Biophys Acta 1052 (1990) 264-272
25. Kumlin M. Measurement of leukotrienes in humans. Am J Respir Crit Care Med 161 (2000) S102-S106
26. Davi G., Guagnano M.T., Ciabattoni G., Basili S., Falco A., Marinopiccoli M., et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288 (2002) 2008-2014
27. Peters-Golden M., Swern A., Bird S.S., Hustad C.M., Grant E., and Edelman J.M. Influence of body mass index on the response to asthma controller agents. Eur Respir J 27 (2006) 495-503
28. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 (2002) 2462-2464
29. Jelic S., Padeletti M., Kawut S.M., Higgins C., Canfield S.M., Onat D., et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117 (2008) 2270-2278
30. Coughlin S.R., Mawdsley L., Mugarza J.A., Wilding J.P., and Calverley P.M. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29 (2007) 720-727
31. Robinson G.V., Pepperell J.C., Segal H.C., Davies R.J., and Stradling J.R. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59 (2004) 777-782